Kaplan–Meier survival analysis indicated that the high expression of PKCβII-AAK1-AP2M1 pathway was significantly associated with prolonged overall survival and relapse-free survival in breast cancer patients (Fig. 6A, B and Supplementary Fig. 9A, B). Here, AP2M1 is linked to breast carcinoma.